XM does not provide services to residents of the United States of America.
G
G

GSK

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Pearson, Softcat, Trelleborg

EUROPE RESEARCH ROUNDUP- Pearson, Softcat, Trelleborg July 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Pearson, Softcat and Trelleborg, on Friday. HIGHLIGHTS * Aker BP ASA AKRBP.OL : Jefferies cuts target price to NOK 340 from NOK 345 * GSK GSK.L : Citigroup cuts target price to 1900p from 2120p * Pearson PSON.L : Deutsche Bank raises target price to 1052p from 1050p * Softcat Plc SCTS.L : Jefferies cuts target price to 1,490p
A
A
B
C
C
D
D
E
E
G
I
K
N
N
P
T
T
T
V
W
A
D
Y

British Business - July 4

PRESS DIGEST-British Business - July 4 July 4 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Dublin-based video game services group Keywords Studios KWS.L has agreed to a bid worth 2.2 billion pounds ($2.80 billion) from European private equity firm EQT EQTAB.ST - A partnership between GSK GSK.L and CureVac 5CV.DE struck during the pandemic has been restructured i
G

Financial Times - July 4

PRESS DIGEST- Financial Times - July 4 July 4 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - EQT strikes 2.2 bln STG deal for Irish video gaming group Keywords Studios - Hawksmoor restaurant chain up for sale - Germany vetoes sale of sensitive turbine unit to Chinese group - GSK signs 1.4 bln euros mRNA vaccine deal with troubled biotech CureVac Overview - A consortium led by Swedish
G
P
V

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Quest Diagnostics, Lufthansa, CoinDCX Updates: Volkswagen July 3 (Reuters - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Wednesday: ** Quest Diagnostics DGX.N said it would acquire Canada-based LifeLabs from pension plan owner OMERS for about C$1.35 billion, or about $985 million, including net debt.
G
L
P
P
V
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions July 3 (Reuters - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Wednesday: ** Germany's cabinet blocked the planned sale of Volkswagen VOWG_p.DE subsidiary MAN Energy Solutions' gas turbine division to a Chinese company, two government sources said. nS8N3IC08R ** A joint venture between Trafigura and the Frontier Group of Companies (FGC) has completed its acquisition of the Mountain Creek power plant from a group of
G
P
P
V
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.